Skip to main content
Caplight Logo









Lynx Biosciences

Lynx Biosciences

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.lynx.bio/

Last Round

Seed

Nov 3, 2021

Total Funding Raised

$2.4M

Company Overview

Lynx Biosciences is a biotechnology company that offers a proprietary ex vivo disease biology platform for drug discovery and development in immuno-oncology and immunology.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

ex vivo platformdrug discovery platformAI drug discoverymulti-omicsbiomarker discoveryimmuno-oncologyCROpatient-derived assaysprecision medicinedeep learning analyticsmicrofluidicsdrug target identificationtumor microenvironment modelingfunctional biologyhematological cancers

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lynx Biosciences Comparables

Compare Lynx Biosciences with similar companies based on industry and business-model similarity.

Lynx Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kiyatec
82%
CanChip GmbH
75%
Merck
71%

Lynx Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 3, 2021
SeedMar 1, 2018

Key People

Founding team and executive leadership

Chorom Pak

CEO Founder

Founding Team

Lynx Biosciences Investors

Notable investors and investment history

Lynx Biosciences investors
InvestorRounds
Great Oaks Venture CapitalSeed
WARF VenturesSeed
Cove FundSeed
Checkmate CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 3, 2021

    Led by Checkmate Capital with participation from Cove Fund, Great Oaks, and WARF Ventures.

Lynx Biosciences Filings

Explore SEC and related filing metadata, where available.

Lynx Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lynx Biosciences's valuation, stock price, and market status.

Is Lynx Biosciences a public or private company?

Lynx Biosciences is a private company.

What is the current stock price of Lynx Biosciences?

Lynx Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Lynx Biosciences worth (valuation)?

Valuation information for Lynx Biosciences is not publicly available.

Can I buy Lynx Biosciences stock?

Lynx Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lynx Biosciences's last funding round?

Funding round information for Lynx Biosciences is not publicly available.

Who are the main investors in Lynx Biosciences?

Investor information for Lynx Biosciences is not publicly disclosed.

Will Lynx Biosciences IPO soon?

No public IPO plans have been announced for Lynx Biosciences.

How can I track Lynx Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lynx Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range12
Year Founded2015
Last FundingNov 3, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?